Poster Session 2

Saturday, 14 December 2013: 12:00 - 13:00
Michigan Ballroom (Westin - Michigan Avenue)
Chairpersons:   João Tebyrica (Brazil), Ruchi Gupta (United States)
2000
2000: A Case Study in Effective Innovative Strategic Multi-modal Recruitment Strategies in Difficult-to-Recruit Patient Populations: Study of Safety and Tolerability of Novel SLIT in an Adolescent Population | Anne Marie Salapatek (Canada)
2001
2001: Generation a hypoallergenic profilin from Amaranthus palmeri pollen | CESAR Manuel Landa (Mexico)
2002
2002: Transfer Factor May Provide Immunomodulation In Cutaneous Tuberculosis | Laura Vidal (Mexico)
2003
2003: Cat-PAD, The First In a New Class Of Synthetic Peptide Immuno-Regulatory Epitopes, Demonstrates a Favourable Safety and Tolerability Profile In Patients With Cat-Induced Rhinoconjunctivitis | Roderick Peter Hafner (United Kingdom)
2004
2004: Bio Immun(G)En Medicine Or How To Link Scientific Research and Daily Therapeutic Practice | Gilbert Glady (France)
2005
2005: Application Of a Standardized Titrated Nasal Provocation Test With HDM and Birch Pollen Extract In Multicentre Clinical Studies In Allergic Rhinitis | Diderik Boot (Netherlands)
2006
2006: Fel d 1 Derived Synthetic Peptide Immune-Regulatory Epitopes Improve Nasal Symptoms Of Cat Allergy 2 Years After Administration Of 4 Doses Over a 12 Week Period | Roderick Peter Hafner (United Kingdom)
2007
2007: Treatment With Fel d 1 Derived Synthetic Peptide Immune-Regulatory Epitopes Results In a Persistent Treatment Effect On Symptoms Of Cat Allergy 2 Years After Treatment With 4 Doses 4 Weeks Apart | Roderick Peter Hafner (United Kingdom)
2008
2008: Sublingual RUSH Immunotherapy | Ramandra Nath Mitra (India)
2009
2009: Clinical Substantiation Of Immunocorrective Therapy In Children With Atopic Dermatitis | Tatiana Slavyanskaya (Russia)
2010
2010: A Study Assessing The Safety and Efficacy Of Subcutaneous Immunotherapy With a Dust Mite Vaccine With The Adjuvant L-Tyrosine In a Highly Sensitized Population In a Latin-American City Jorge F Maspero (Argentina)
2011
2011: A DNA Vaccine Immunotherapy For Japanese Red Cedar Allergy | Lawrence Weiner (United States)
2012
2012: House Dust Mite Sublingual Immunotherapy With Standardized Vaccines: Prescription and Adverse Events | Alexander Diaz Rodriguez (Cuba)
2013
2013: The Safety Of The United Allergy Services Immunotherapy Protocol | Frederick Schaffer (United States)
2014
2014: A Survey Of Respiratory Physicians' Opinion Of SIT In Asthma Treatment In Wuhan Of China | Rongfei Zhu (China)
2015
2015: Quality Of Life Improvement With Sublingual Immunotherapy: A Prospective Study Of Efficacy | Mary S. Morris (United States)
2016
2016: The Effect and Value Of Sublingual Immunotherapy: A Patient Survey | Mary S. Morris (United States)
2017
2017: Molecular Profiles Of IgE To Timothy Grass Allergens In Patients Screened For Grass Tablet Immunotherapy Hendrik Nolte (United States)
2018
2018: Efficacy and Safety Of Grass Sublingual Immunotherapy Tablet (SLIT-T) Treatment In a Large Randomized Controlled Trial In North American Children and Adults | Hendrik Nolte (United States)
2019
2019: Grass Sublingual Immunotherapy Tablet (SLIT-T) Treatment Is Associated With Similar Efficacy and Safety In Children and Adults: Subgroup Analysis Of Data From a Large North American Trial | Hendrik Nolte (United States)
2020
2020: Effect Of Sublingual Immunotherapy Tablet (SLIT-T) Treatment On Daily Medication Score Using Alternative Scoring Methods Based On WAO Recommendations Hendrik Nolte (United States)
2021
2021: The Incidence Of Adverse Reactions Induced By Subcutaneous Immunotherapy In An Allergy Center In Monterrey, México: A Retrospective Chart Review Lorena Rangel (Mexico)
2022
2022: Sublingual Immunotherapy In The Treatment Of Allergic Rhinitis: Series Of Cases Lorena Rangel-Garza (Mexico)
See more of: Poster Sessions
<< Previous Session | Next Session >>